S. Sakura Minami
Vice President, Translational Medicine & Nonclinical Development Iron Fist Therapeutics
Seminars
Wednesday 22nd July 2026
Modulating Tumor Microenvironment– Mediated Resistance Mechanisms to Enhance Therapeutic Response in Preclinical Models
12:00 pm
- Immune modulation of the TME as a strategy to enhance anti-tumor immunity
- Combinatorial therapeutic strategies to leverage TME modulation with anti-tumor immunotherapies
- Targeting the TME with preclinical interventions
Thursday 23rd July 2026
Roundtable Discussion: Shaping the Future of Combination Radioligand Therapy: Preclinical Perspectives
2:30 pm
- Balancing toxicity and efficacy: minimizing radiopharmaceutical dose while enhancing tumor kill
- Timing combination therapies: strategies for preclinical-to-clinical translation
- Selecting patients using biomarkers to match optimal RLT combinations with tumor and TME characteristics
